Trinity Biotech PLC (NASDAQ:TRIB)

Delayed Data
As of Apr 20
 +0.11 / +2.25%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Trinity Biotech PLC have a median target of 7.50, with a high estimate of 8.00 and a low estimate of 7.00. The median estimate represents a +50.00% increase from the last price of 5.00.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Trinity Biotech PLC. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Apr 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -54.55%
Growthannually -35.80%


Growthquarterly -1.08%
Growthannually 0.97%
Key to the earnings and sales forecast charts.